ICIM - 2007 Conference

Metal Toxicity and the Impact on Human Health,
Remedies and Rationale
Presented by the
International College of Integrative Medicine
Sheraton Station Square, Pittsburgh, PA

Learning Objectives - Lead-In Workshop (Click Here)

Wednesday, October 1, 2008

7:45-8:00	Welcome and introduction
8:00-10:00	Necessity of Paying Attention to Toxic Metals - News Reports – Scientific Reports - Where these toxic metals come from - How do they cause problems for the human - How are they identified in individual patients. David Quig, PhD, St Charles, IL http://www.yourmedicaldetective.com/public/198.cfm
10:00-10:30	Nutrition Break
10:30-11:30	Lifelong Consequences of Early low to Moderate Exposure to lead: Neuroanatomical and Social Behavioral Outcome Kim Dietrich, PhD, Cincinnati Children’s Center for Environmental Health, Cincinnati, OH http://www.eh.uc.edu/dir_individual_details.asp?qcontactid=52
11:30-12:30	Mercury and Manganese -Other metals involved in intelligence disruption? Michael Aschner, PhD, Vanderbilt University, Nashville TN http://www1.wfubmc.edu/PhysPharm/adjunctfaculty/Aschner.htm
12:30-1:30	Lunch
1:30-2:30	History of Chelating Agents EDTA – DMPS – DMSA John Trowbridge, MD, Life Celebrating Health, Humble, Texas http://www.arthritistrust.org/Directors/Trowbridge.htm
2:30-3:30	Introduction to Chelating Agents from a Chemistry Point of View How and Why They Work Ted Rozema, MD, BioGenesis Wellness/Medical Center, Landrum, SC
3:30-4:00	Nutrition Break
4:00-5:00	Autism: Thimerosal, DMPS & DMSA Vasken Aposhian, PhD, Professor, Department of Molecular & Cellular Biology, University of Arizona, Tucson, AZ http://bmcb.biology.arizona.edu/aposhian.html http://toxsci.oxfordjournals.org/cgi/content/abstract/4/2part2/58
5:00-6:00	Specific Chelators EDTA Chemistry and Mechanism of Action EDTA Toxicity – how to protect the patient Ted Rozema, MD, BioGenesis Wellness/Medical Center, Landrum, SC

(Click on presenter's name to view their CV)

Thursday, October 2, 2008

8:00-8:45	DMPS – DMSA Toxicity – How to Protect the Patient David Quig, PhD, St Charles, IL
8:45-10:15	Rationale and Therapeutic Use of DMSA, DMPS, D-Penicillamine and CaNa2EDTA in Heavy Metal Intoxication and Exposure: Implications for Children and Adults. Jeff Bradstreet, MD, International Child Development Resource Center, Melbourne, FL http://www.icdrc.org/Bradstreet.html
10:15-10:45	Nutrition Break
10:45-11:45	Protocol for Clinical use of both Mg2NaEDTA and CaNa2EDTA Ted Rozema, MD, BioGenesis Wellness/Medical Center, Landrum, SC
11:45-12:30	Supporting Evidence for Mg2NaEDTA use in Degenerative and Vascular Disease Terry Chappell, MD, Celebration of Health Association, Bluffton, OH http://www.healthcelebration.com
12:30-1:30	Lunch
1:30-2:30	Atherosclerosis/Angiogenesis – Pathophysiology of Atherosclerotic Disease Stephen Olmstead, MD - Cardiologist
2:30-3:30	Mitochondrial Pathophysiology, Implication of Toxic Metals, Restoration of Oxidative Function Efrain Olszewer, MD – Clinical Cardiologist, Sao Paulo, Brazil http://www.medicineonearth.com/display.php?id=661
3:30-4:00	Nutrition Break
4:00-5:00	Chemistry and Creation of new Chelating Agents – From the Laboratory to the Human Swaran Flora, MD, Division of Pharmacology and Toxicology, Defence Research and Development Establishment, Gwalior, India http://jpet.aspetjournals.org/cgi/content/abstract/322/1/108
5:00-6:00	Panel Discussion of Presenters with Audience Participation Ask those questions you always wanted to, but did not have the experts to give you the proper answers.

(Click on presenter's name to view their CV)